Invasive Group A Streptococcal Infections: Benefit of Clindamycin, Intravenous Immunoglobulins and Secondary Prophylaxis

Invasive Group A Streptococcal Infections: Benefit of Clindamycin, Intravenous Immunoglobulins and Secondary Prophylaxis

Introduction: Mortality associated with invasive group A streptococcal infections (iGAS) remains high among adults, with lower mortality in children. The added value of both clindamycin and immunoglobulins in such treatment is still controversial, as is the need for antibiotic secondary prophylaxis....

Full description

Bibliographic Details
Main Authors: Delphine Laho, Sophie Blumental, Anne Botteaux, Pierre R. Smeesters
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Pediatrics
Subjects:
invasive group A streptococcal infections
clindamycin
immunoglobulins
secondary prophylaxis
chemoprophylaxis
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2021.697938/full

Similar Items

Similar Items